Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Disease
100%
Cardiovascular System
72%
Malignant Neoplasm
56%
Neoplasm
56%
Heart Failure
55%
Hepatocellular Carcinoma
54%
Cardiovascular Disease
51%
Diabetes
48%
Maturity Onset Diabetes of the Young
43%
Infection
43%
Prevalence
39%
Chronic Kidney Disease
38%
Biological Marker
37%
Lung Cancer
33%
Percutaneous Coronary Intervention
33%
Clinical Trial
33%
Non Small Cell Lung Cancer
32%
Hazard Ratio
32%
Isotopes of Calcium
31%
Drug Therapy
30%
Human Immunodeficiency Virus
28%
Chronic Total Occlusion
28%
Placebo
27%
Blood Pressure
27%
COVID-19
27%
Meta-Analysis
27%
Odds Ratio
27%
Health Care Cost
26%
Symptom
26%
Liver Cirrhosis
26%
Myocardial Infarction
26%
Diagnosis
25%
Diabetes Mellitus
25%
Resuscitation
25%
Overall Survival
24%
Adverse Event
23%
Urinary System
23%
Cohort Analysis
22%
Clear Cell Renal Cell Carcinoma
22%
Breast Cancer
22%
Clinician
22%
Transplantation
22%
Kidney Stone
21%
Body Mass Index
21%
Apoplexy
21%
Nephropathy
20%
Magnetic Resonance Imaging
19%
Liver Transplantation
19%
Cardiovascular Risk
19%
Injury
19%
Systematic Review
19%
Atherosclerosis
19%
Oncology
18%
Small Cell Lung Cancer
18%
Combination Therapy
17%
Radiation Therapy
17%
Randomized Controlled Trial
16%
In Vitro
16%
Quality of Life
16%
Heart Arrest
16%
Pediatrics
16%
Surgery
15%
Hemodynamic
15%
Kidney Function
15%
Congestive Heart Failure
15%
Exercise
15%
Heart Failure with Preserved Ejection Fraction
15%
Acute Kidney Injury
15%
Coronary Artery Disease
15%
Liver Disease
14%
Metastatic Carcinoma
14%
Medicare
14%
Patient with Type 2 Diabetes
14%
Barrett Esophagus
14%
Cancer
14%
Health Care
14%
Biopsy
14%
Adipose Tissue
14%
Coronary Artery
13%
Pathophysiology
13%
Revascularization
13%
Acute Liver Failure
13%
Primary Health Care
13%
Acute Heart Infarction
13%
Insulin Resistance
13%
Recurrent Disease
13%
Bleeding
13%
Atrial Fibrillation
13%
Ischemic Heart Disease
12%
Cohort Effect
12%
Statin
12%
Lung Transplantation
12%
Diseases
12%
Out of Hospital Cardiac Arrest
12%
Metabolic Syndrome
12%
Pulmonary Hypertension
12%
Outpatient
12%
Logistic Regression Analysis
12%
Immunotherapy
12%
Arm
11%
Biochemistry, Genetics and Molecular Biology
Mouse
98%
Genetics
40%
Enzyme
39%
Eicosanoid Receptor
35%
Low-Density Lipoprotein
32%
Adipocyte
30%
Cancer Cell
29%
Metabolic Pathway
28%
Autophagy
26%
Blood Pressure
25%
Lipid
25%
Insulin Resistance
24%
Triglyceride
23%
LDL Receptor
23%
Promoter Region
23%
Gene Expression
22%
Messenger RNA
22%
Allele
22%
Fibroblast
22%
Oxidoreductase
21%
Kinase
20%
Phosphotransferase
20%
Homeostasis
20%
Prevalence
20%
Transcription Factors
19%
Sterol
18%
Lipoprotein
17%
Amino Acids
17%
Cardiac Muscle Cell
17%
N-Terminus
16%
Transcription
16%
Adenosine Triphosphate
15%
Normal Human
15%
Wild Type
15%
Clinical Trial
15%
Skeletal Muscle
15%
Carcinogenesis
15%
Mouse Model
14%
Epidermal Growth Factor Receptor
14%
Adiponectin
14%
Signal Transduction
13%
Cohort Study
13%
Telomerase
13%
Secretion (Process)
13%
Isoform
13%
Glucagon
13%
Surface Property
12%
Magnetism
12%
Overall Survival
12%
Body Mass
11%
Telomere
11%
Reductase
11%
Glucose Blood Level
11%
Mitochondrion
11%
Sterol Regulatory Element-Binding Protein
11%
Knockout Mouse
11%
T Cell
11%
Insulin Sensitivity
11%
Familial Hypercholesterolemia
11%
Precursor
10%
Hepatocyte
10%
P53
10%
Leptin
10%
Cholesterol Synthesis
10%
Exon
10%
Methylation
10%
Metabolite
10%
Cell Membrane
10%
C-Terminus
9%
Natriuretic Peptide
9%
Synapsin I
9%
Heart Ejection Fraction
9%
Blood Level
9%
Hyperglycemia
9%
Binding Protein
9%
Tumor Progression
9%
Cholesterol Blood Level
9%
Bile Acid
9%
Hypercholesterolemia
9%
Macrophage
9%
Transgenic Mouse
9%
Alpha Oxidation
8%
Monospecific Antibody
8%
Tumor Suppressor Gene
8%
Human Immunodeficiency Virus
8%
Gene Mutation
8%
Absorption
8%
HDL-Cholesterol
8%
Glomerulus Filtration
8%
Cell Proliferation
8%
Oxidative Stress
8%
Stem Cell
8%
Binding Site
8%
Tumor Suppressor Protein
8%
Hypertriglyceridemia
8%
Cell Death
8%
Lipogenesis
8%
Androgen Receptor
8%
Dehydrogenase
8%
Kidney Function
7%
Keyphrases
Confidence Interval
35%
Type 2 Diabetes Mellitus (T2DM)
30%
Heart Failure
28%
Hepatocellular Carcinoma
25%
United States
24%
Obesity
24%
Diabetes
23%
Placebo
22%
Liver
22%
Hazard Ratio
21%
Chronic Kidney Disease
21%
Hypertension
20%
Cholesterol
20%
High Risk
19%
Insulin
18%
Low-density Lipoprotein
18%
Non-small Cell Lung Cancer (NSCLC)
17%
Risk Factors
16%
Clinical Outcomes
16%
Cardiovascular Disease
16%
Tumor
15%
Type 2 Diabetic Patients
15%
Kidney
15%
Heart Failure with Preserved Ejection Fraction (HFpEF)
15%
Cardiovascular Risk
15%
COVID-19
15%
Type 1 Diabetes Mellitus (T1DM)
14%
Overall Survival
14%
Percutaneous Coronary Intervention
14%
Cirrhosis
14%
Odds Ratio
14%
Myocardial Infarction
13%
Clinical Trials
13%
Lung Cancer
13%
Chemotherapy
13%
Meta-analysis
13%
Low-density Lipoprotein Receptor
12%
Blood Pressure
12%
Chronic Total Occlusion
12%
Cardiovascular Outcomes
12%
Lipoproteins
11%
Liver Transplantation
11%
Coronary Artery Disease
11%
Older Adults
11%
Atherosclerotic Cardiovascular Disease (ASCVD)
10%
Autophagy
10%
Insulin Resistance
10%
Adipose Tissue
10%
Small Cell Lung Cancer
10%
Low-density Lipoprotein Cholesterol (LDL-C)
10%
Glucagon
10%
High-density Lipoprotein Cholesterol (HDL-C)
10%
Cardiovascular Mortality
10%
Hospitalization
9%
Metabolic Syndrome
9%
Randomized Clinical Trial
9%
Inflammation
9%
Statins
9%
Sterol Regulatory Element-binding protein-1c (SREBP-1c)
9%
Cardiovascular Events
9%
T Cells
9%
Body Mass Index
9%
Randomized Controlled Trial
9%
Barrett's Esophagus
8%
Patients with Diabetes
8%
Acute Liver Failure
8%
All-cause Mortality
8%
Leptin
8%
Adipocyte
8%
Phase II Trial
8%
Systemic Lupus Erythematosus
8%
Patients with Heart Failure
8%
Monoclonal Antibody
8%
Renal Cell Carcinoma
8%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
8%
Immune Checkpoint Inhibitors
7%
Cholesterol Levels
7%
Metabolism
7%
Adverse Events
7%
Acute Kidney Injury
7%
Rheumatoid Arthritis
7%
Lung
7%
Hypertension Management
7%
Homozygous Familial Hypercholesterolemia (HoFH)
7%
Dallas Heart Study
7%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
7%
Hepatocellular Carcinoma Surveillance
7%
Systematic Meta-analysis
7%
Heart Failure Hospitalization
7%
Hemoglobin A1c (HbA1c)
7%
Randomized Trial
7%
Acute Myocardial Infarction
7%
Na +
7%
Acute Coronary Syndrome
6%
Atrial Fibrillation
6%
Glucagon-like
6%
Gene Expression
6%
Overexpression
6%
Progression-free Survival
6%
Comorbidity
6%